ETON Eton Pharmaceuticals, Inc.companySEC Filings & Insider Trading Activity 2026
Latest Eton Pharmaceuticals, Inc. (ETON) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on March 19, 2026, a 10-Q quarterly report filed on November 6, 2025, an 8-K current report filed on May 1, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Eton Pharmaceuticals, Inc. (ETON) (SEC CIK 1710340), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Eton Pharmaceuticals, Inc. (ETON) 8-K current reports disclosing material events.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | May 1, 2026 | — | — | — |
8-K | Apr 27, 2026 | — | — | — |
8-K | Apr 16, 2026 | — | — | — |
8-K | Apr 15, 2026 | — | — | — |
10-K | Mar 19, 2026 | Dec 31, 2025 | — | |
8-K | Mar 19, 2026 | — | Analysis | — |
8-K | Mar 2, 2026 | — | Analysis | — |
8-K | Feb 25, 2026 | — | Analysis | — |
8-K | Feb 2, 2026 | — | — | |
8-K | Dec 4, 2025 | — | — | |
10-Q | Nov 6, 2025 | Sep 30, 2025 | — | |
10-Q | Aug 7, 2025 | Jun 30, 2025 | — | |
10-Q | May 13, 2025 | Mar 31, 2025 | — | |
10-K | Mar 18, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 12, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 8, 2024 | Jun 30, 2024 | — | |
10-Q | May 9, 2024 | Mar 31, 2024 | — | |
10-K | Mar 14, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 9, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 10, 2023 | Jun 30, 2023 | — | |
10-Q | May 11, 2023 | Mar 31, 2023 | — | |
10-K | Mar 16, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 10, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 11, 2022 | Jun 30, 2022 | — | |
10-Q | May 12, 2022 | Mar 31, 2022 | — |
Frequently Asked Questions
What are the latest ETON SEC filings in 2026?
Eton Pharmaceuticals, Inc. (ETON) has filed a 10-K annual report on March 19, 2026, a 10-Q quarterly report on November 6, 2025, an 8-K current report on May 1, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did ETON file its most recent 10-K annual report?
Eton Pharmaceuticals, Inc. (ETON) filed its most recent 10-K annual report on March 19, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view ETON 10-Q quarterly reports?
Eton Pharmaceuticals, Inc. (ETON)'s most recent 10-Q quarterly report was filed on November 6, 2025. SignalX displays every ETON 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has ETON filed recently?
Eton Pharmaceuticals, Inc. (ETON)'s most recent 8-K was filed on May 1, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find ETON insider trading activity (Form 4)?
SignalX aggregates every ETON Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does ETON file with the SEC?
Eton Pharmaceuticals, Inc. (ETON) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new ETON filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Eton Pharmaceuticals, Inc. (ETON).
What is ETON's SEC CIK number?
Eton Pharmaceuticals, Inc. (ETON)'s SEC CIK (Central Index Key) number is 1710340. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1710340 to look up all ETON filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find ETON return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Eton Pharmaceuticals, Inc. (ETON) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Eton Pharmaceuticals, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 39+ filings.